Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 25, 2022

SELL
$0.99 - $1.6 $636 - $1,028
-643 Closed
0 $0
Q4 2021

Jan 26, 2022

BUY
$1.22 - $1.72 $784 - $1,105
643 New
643 $1,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.54B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Country Trust Bank Portfolio

Follow Country Trust Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Country Trust Bank, based on Form 13F filings with the SEC.

News

Stay updated on Country Trust Bank with notifications on news.